UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): July 23, 2020
 ns-logoxdarkgreen1.jpg
NATURE’S SUNSHINE PRODUCTS, INC.
(Exact name of registrant specified in its charter)
 
Utah 001-34483 87-0327982
(State or other jurisdiction of
incorporation)
 (Commission File Number) (I.R.S. Employer Identification No.)
 
2901 West Bluegrass Blvd., Suite 100, Lehi, Utah 84043
(Address of principal executive offices) (Zip Code)
 
Registrant’s telephone, including area code:  (801) 341-7900
 
N/A
(Former name and former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, no par valueNATRNasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 23, 2020, Nature's Sunshine Products, Inc. (the "Company") appointed Ms. Heidi Wissmiller to its Board of Directors. Ms. Wissmiller was appointed to serve as a director until the next shareholders’ meeting at which directors are elected. Ms. Wissmiller will initially serve on the Audit and Risk Management Committees.

Ms. Wissmiller, 55, served in multiple C-suite positions for Rodan + Fields from 2014 to April 2019, including chief growth officer and chief operating officer of global field sales and operations. Prior to Rodan + Fields, Ms. Wissmiller was the CEO for Micro Analytical Systems. She previously served in various senior leadership roles with globally recognized companies, including PepsiCo, E & J Gallo Winery and Nabisco.

The Board of Directors determined that Ms. Wissmiller is an independent director under the current standards for independence established by NASDAQ.




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 NATURE’S SUNSHINE PRODUCTS, INC.
   
Dated: July 29, 2020By:/s/ Nathan G. Brower
  Nathan G. Brower, Executive Vice President, General Counsel and Secretary